0001815476-22-000006.txt : 20220822 0001815476-22-000006.hdr.sgml : 20220822 20220822162409 ACCESSION NUMBER: 0001815476-22-000006 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220822 DATE AS OF CHANGE: 20220822 EFFECTIVENESS DATE: 20220822 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Braxia Scientific Corp. CENTRAL INDEX KEY: 0001815476 IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-456582 FILM NUMBER: 221184022 BUSINESS ADDRESS: STREET 1: 2300 - 1177 WEST HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6E2K3 BUSINESS PHONE: 6045259409 MAIL ADDRESS: STREET 1: 2300 - 1177 WEST HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6E2K3 FORMER COMPANY: FORMER CONFORMED NAME: Champignon Brands Inc. DATE OF NAME CHANGE: 20200618 D 1 primary_doc.xml X0708 D LIVE 0001815476 Braxia Scientific Corp. 700 Bay Street Suite 1903 Toronto A6 ONTARIO, CANADA M5G 1Z6 416-762-2138 BRITISH COLUMBIA, CANADA Champignon Brands Inc. Corporation true 2019 Roger S. McIntyre 700 Bay Street Suite 1903 Toronto A6 ONTARIO, CANADA M5G 1Z6 Executive Officer Director Stephen Brooks 700 Bay Street Suite 1903 Toronto A6 ONTARIO, CANADA M5G 1Z6 Executive Officer Peter Rizakos 700 Bay Street Suite 1903 Toronto A6 ONTARIO, CANADA M5G 1Z6 Executive Officer Joshua Rosenblat 700 Bay Street Suite 1903 Toronto A6 ONTARIO, CANADA M5G 1Z6 Executive Officer Kevin Kratiuk 700 Bay Street Suite 1903 Toronto A6 ONTARIO, CANADA M5G 1Z6 Executive Officer Olga Cwiek 700 Bay Street Suite 1903 Toronto A6 ONTARIO, CANADA M5G 1Z6 Director Jerry Habuda 700 Bay Street Suite 1903 Toronto A6 ONTARIO, CANADA M5G 1Z6 Director Other Health Care Decline to Disclose 06b false 2022-08-02 false true true Convertible Debentures that can be converted into Common Shares of the Issuer prior to December 15, 2023, and expire on December 31, 2023 true 0 2283537 2283537 0 U.S. dollar amounts are based on the Bank of Canada average rate of exchange reported on August 2, 2022, which was CDN$1.2856 = USD$1.00. false 35 0 0 0 In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors. false Braxia Scientific Corp. Peter Rizakos Peter Rizakos General Counsel 2022-08-17